Stabilized microbubble compositions

Abstract

A microbubble preparation formed of a plurality of microbubbles comprising a first gas and a second gas surrounded by a membrane such as a surfactant, wherein the first gas and the second gas are present in a molar ratio of from about 1:100 to about 1000:1, and wherein the first gas has a vapor pressure of at least about (760−x) mm Hg at 37° C., where x is the vapor pressure of the second gas at 37° C., and wherein the vapor pressure of each of the first and second gases is greater than about 75 mm Hg at 37° C.; also disclosed are methods for preparing microbubble compositions, including compositions that rapidly shrink from a first average diameter to a second average diameter less than about 75% of the first average diameter and are stabilized at the second average diameter; kits for preparing microbubbles; and methods for using such microbubbles as ultrasound contrast agents

What is claimed is:  
     
         1 . A microbubble for the in vivo transport of physiological gases wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas wherein the microbubble grows and shrinks to maintain osmotic equilibrium with the physiological gas saturation of the surrounding external medium.  
     
     
         2 . The microbubble of  claim 1  wherein the modifier gas saturation level changes in the bubble as the microbubble circulates.  
     
     
         3 . The microbubble of  claim 1  wherein the surrounding external medium is blood.  
     
     
         4 . The microbubble of  claim 1  wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas while in vivo.  
     
     
         5 . The microbubble of  claim 1  wherein the physiological gases are at least one gas selected from the group consisting of oxygen, nitrogen and carbon dioxide.  
     
     
         6 . The microbubble of  claim 1  wherein the microbubble grows when the modifier gas of the microbubble exchanges with gases present in the surrounding external medium.  
     
     
         7 . The microbubble of  claim 6  wherein the physiological gas present in the surrounding external medium is oxygen.  
     
     
         8 . The microbubble of  claim 6  wherein the physiological gas present in the surrounding external medium is air.  
     
     
         9 . The microbubble of  claim 1  wherein the at least one fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, perfluoromethylcyclohexanes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, perfluorotriethylamines, and sulfur hexafluoride.  
     
     
         10 . A microbubble for in vivo delivery of physiological gases to an organism or tissues of an organism wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas comprising oxygen wherein the microbubble grows or shrinks in diameter to maintain osmotic equilibrium with the surrounding external medium.  
     
     
         11 . The microbubble composition of  claim 10  wherein the fluorocarbon gas is perfluorohexane.  
     
     
         12 . The microbubble of  claim 10  wherein the microbubble grows in diameter to maintain osmotic equilibrium of oxygen within the microbubble with the oxygen in the surrounding medium.  
     
     
         13 . The microbubble of  claim 10  wherein the surrounding external medium is blood.  
     
     
         14 . The microbubble of  claim 10  wherein the one fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, perfluoromethylcyclohexanes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, perfluorotriethylamines, and sulfur hexafluoride.  
     
     
         15 . The microbubble of  claim 10  wherein the microbubble further comprises a membrane.  
     
     
         16 . The microbubble of  claim 11  wherein the microbubble further comprises a membrane.  
     
     
         17 . A microbubble composition for the in vivo transport of physiological gases wherein the microbubble comprises at least one fluorocarbon gas and at least one modifier gas wherein the microbubble first shrinks as a result of loss of the modifier gas to the surrounding medium and then grows as the microbubble gains osmotic equilibrium with the physiological gas saturation of the surrounding medium.  
     
     
         18 . The microbubble composition of  claim 17  wherein the modifier gas is selected from the group consisting of oxygen, nitrogen and carbon dioxide.  
     
     
         19 . The microbubble composition of  claim 17  wherein the transported physiological gas is oxygen.  
     
     
         20 . The microbubble composition of  claim 17  wherein the fluorocarbon gas is selected from the group consisting of perfluoropropanes, perfluorobutanes, perfluorocyclobutanes, perfluoropentanes, perfluorocyclopentanes, perfluoromethylcyclopentanes, perfluorohexanes, perfluorocyclohexanes, perfluoromethylcyclopentanes, perfluorodimethylcyclobutanes, perfluoroheptanes, perfluorocycloheptanes, per fluoromethylcyclohex anes, perfluorodimethylcyclopentanes, perfluorotrimethylcyclobutanes, perfluorotriethylamines, and sulfur hexafluoride.